XML 65 R41.htm IDEA: XBRL DOCUMENT v2.4.0.6
Financial Instruments and Fair Value Measures (Details 4) (USD $)
In Millions, unless otherwise specified
3 Months Ended 12 Months Ended
Mar. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Reconciliation of the fair value measurements that use significant unobservable inputs (Level 3)      
Fair value at the beginning of the period $ 251    
Payments (131)    
Other (5)    
Loss recognized in earnings 3    
Fair value at the end of the period 118    
Transfers of assets or liabilities between the fair value measurement levels      
Transfer of assets from level 1 to level 2 0 0  
Transfer of assets from level 2 to level 1 0 0  
Transfer of liabilities from level 1 to level 2 0 0  
Transfer of liabilities from level 2 to level 1 0 0  
Contingent payments related to acquisitions | Solvay SA Pharmaceuticals
     
Reconciliation of the fair value measurements that use significant unobservable inputs (Level 3)      
Fair value at the beginning of the period 251 349 295
Payments (131) (134)  
Other   7 (2)
Loss recognized in earnings   29 56
Fair value at the end of the period   $ 251 $ 349